Is alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?

By  

Current Alzheimer Research, Vol. 4, Iss. 4, 2007-09 ,pp. : 446-457

Bentham Science Publishers

Access to resources Recommend Favorite

Metal Catalyzed Oxidation of Alpha-Synuclein - A Role for Oligomerization in Pathology?

By  

Current Alzheimer Research, Vol. 5, Iss. 6, 2008-12 ,pp. : 599-606

Bentham Science Publishers

Access to resources Recommend Favorite

β-synuclein-derived peptides with neuroprotective activity: An alternative treatment of neurodegenerative disorders?

By Windisch Manfred   Hutter-Paier Birgit   Schreiner Edith   Wronski Robert  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 155-165

Humana Press, Inc

Access to resources Recommend Favorite

A novel progranulin mutation associated with variable clinical presentation and tau , TDP43 and alpha-synuclein pathology

By Leverenz J. B.  

Brain, Vol. 130, Iss. 5, 2007-05 ,pp. : 1360-1374

Oxford University Press

Access to resources Recommend Favorite

Lack of Alpha-Synuclein Modulates Microglial Phenotype In Vitro

By Austin Susan   Rojanathammanee Lalida   Golovko Mikhail   Murphy Eric   Combs Colin  

Neurochemical Research, Vol. 36, Iss. 6, 2011-06 ,pp. : 994-1004

Springer Publishing Company

Access to resources Recommend Favorite